论文信息 - 49LBA Final results of a Phase II randomised study of cediranib (RECENTIN™) in patients with advanced renal cell carcinoma (RCC) - 字舞流文

49LBA Final results of a Phase II randomised study of cediranib (RECENTIN™) in patients with advanced renal cell carcinoma (RCC)

M. Gore | P. Mulders | E. Porfiri | R. Hawkins | P. Nathan | B. Mookerjee | L. Pike | S. Osanto | A. Protheroe | D. Jong | M. Gore | Bijoyesh Mookerjee